Briefly, the study is outlined as follows: ChEMBL database screening with the aromatase target protein and exploration of the various in-silico strategies for regulating the biological processes involved in breast cancer progression and validation of the compound in in-vitro conditions. Here, CYP19A1 is linked to breast carcinoma.